Interestingly, HA tetrasaccharides can improve outcomes after spinal cord injury in a CD44 and TLR4 dependent manner [174], and also protect hippocampal neurons during ischemia through the inhibition of TLR2 signaling [175]. The gene discussed is TLR4; the disease is ischemia.